Prazosin hydrochloride
Tocris Bioscience, part of Bio-Techne | Catalog # 0623
α1 and α2B antagonist; also MT3 antagonist
Key Product Details
Description
α1 and α2B antagonist; also MT3 antagonist
Product Description
Prazosin hydrochloride is an α1 and α2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). In prostate cancer cells, Prazosin induces DNA damage stress, Cdk1 inactivation, G2 checkpoint arrest and apoptosis. In mice bearing prostate cancer xenografts, oral administration of Prazosin reduces tumor mass.Product Specifications
Molecular Weight
419.87
Formula
C19H21N5O4.HCl
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hydrochloride
CAS Number
19237-84-4
PubChem ID
68546
InChI Key
WFXFYZULCQKPIP-UHFFFAOYSA-N
SMILES
Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1=CC=CO1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 25 | ||
| Ethanol | 5 |
Preparing Stock Solutions
for Prazosin hydrochloride
The following data is based on the product molecular weight 419.87
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.25 mM | 9.53 mL | 47.63 mL | 95.27 mL |
| 1.25 mM | 1.91 mL | 9.53 mL | 19.05 mL |
| 2.5 mM | 0.95 mL | 4.76 mL | 9.53 mL |
| 12.5 mM | 0.19 mL | 0.95 mL | 1.91 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Lin Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia 2007 PMID: 17971903
- Paul Characterisation of 2-[125I]iodomelatonin binding sites in syrian hamster peripheral organs. J.Pharmacol.Exp.Ther. 1999 PMID: 10381796
- Pickering and Niles Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus. Eur.J.Pharmacol. 1990 PMID: 2157597
- Mathe Prazosin inhibits MK-801-induced hyperlocomotion and DA release in the nucleus accumbens. Eur.J.Pharmacol. 1996 PMID: 8864686
Product Specific Notices for Prazosin hydrochloride
For research use only
Loading...
Loading...